BC
DFTX

BIT Capital’s Definium Therapeutics DFTX Stock Holding History

BIT Capital’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.24M Buy
+277,511
New +$4.71M 0.25% 43
2025
Q4 		– Sell
-2,245
Closed -$26.5K – 131
2025
Q3 		$26.5K Buy
+2,245
New +$20.9K ﹤0.01% 109
2025
Q1 		– Sell
-63,405
Closed -$441K – 135
2024
Q4 		$441K Buy
+63,405
New +$436K 0.04% 84
2022
Q1 		– Sell
-9,333
Closed -$193K – 173
2021
Q4 		$193K Hold
9,333
– – 0.01% 108
2021
Q3 		$326K Hold
9,333
– – 0.02% 86
2021
Q2 		$483K Buy
+9,333
New +$490K 0.03% 79

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT Capital's DFTX Position: Q1 2026 in Review

BIT Capital opened a new position in Definium Therapeutics (DFTX) in Q1 2026: 277,511 shares worth $5.24M. The stake represents 0.25% of the portfolio and ranks #43 among its holdings. This is a return to the name: BIT Capital previously reported a position in DFTX as recently as Q3 2025.

BIT Capital first reported a position in DFTX in Q2 2021 and has held it in 6 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • BIT Capital held 277,511 shares of Definium Therapeutics worth $5.24M as of Q1 2026.
  • Definium Therapeutics was a new BIT Capital position in Q1 2026.
  • Definium Therapeutics made up 0.25% of BIT Capital's portfolio in Q1 2026, its #43 holding.
  • BIT Capital first reported a position in Definium Therapeutics in Q2 2021 and has held it in 6 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on BIT Capital's 13F filing for Q1 2026, filed 13 May 2026.